Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Arthritis Research & Therapy|March 13, 2012
The anti-CD74 humanized monoclonal antibody, milatuzumab, which targets the invariant chain of MHC II complexes, alters B-cell proliferation, migration, and adhesion molecule expressionDaniela Frölich, Daniela Blassfeld, Karin Reiter, et al.Blood|September 11, 2010
Steady-state generation of mucosal IgA+ plasmablasts is not abrogated by B-cell depletion therapy with rituximabHenrik E Mei, Daniela Frölich, Claudia Giesecke, et al.RMD Open|January 27, 2017
SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndromeThomas Rose, Franziska Szelinski, Anna Lisney, et al.Frontiers in Immunology|February 12, 2019
Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus NephritisMariele Gatto, Annika Wiedemann, Nadja Nomovi, et al.Arthritis and Rheumatism|June 3, 2008
Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95Annett M Jacobi, Karin Reiter, Meggan Mackay, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 26, 2014
Tissue distribution and dependence of responsiveness of human antigen-specific memory B cellsClaudia Giesecke, Daniela Frölich, Karin Reiter, et al.Frontiers in Immunology|May 10, 2021
BTLA Expression and Function Are Impaired on SLE B CellsAnnika Wiedemann, Marie Lettau, Sarah Y Weißenberg, et al.Arthritis & Rheumatology (Hoboken, N.J.)|May 4, 2022
Plasmablast-like Phenotype Among Antigen-Experienced CXCR5-CD19low B Cells in Systemic Lupus ErythematosusFranziska Szelinski, Ana Luisa Stefanski, Eva Schrezenmeier, et al.Pageof 2